Skip to main content
Caplight Logo









Axora Medical

Axora Medical

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://axoramedical.com/

Last Round

Private Placement

Oct 1, 2023

Est. Valuation

$56.33M

Total Funding Raised

$128.6M

Company Overview

Axora Medical is a medical technology company that provides a portfolio of minimally invasive diagnostic and treatment solutions for gynecologic conditions, including abnormal uterine bleeding.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

minimally invasive surgerygynecological devicesabnormal uterine bleedingAUBendometrial ablationhysteroscopyuterine fibroid removalpolyp removalsurgical disposablesambulatory surgery centersASCsgyn surgerymedical device manufacturerwomen's health techfemtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axora Medical Comparables

Compare Axora Medical with similar companies based on industry and business-model similarity.

Axora Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Channel Medsystems, Inc.
85%
Caldera Medical
79%
LiNA Medical
78%

Axora Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementOct 1, 2023
Private PlacementFeb 9, 2023
IPOOct 26, 2021
Series DMay 12, 2020
Series C ExtensionDec 27, 2016
Series C
Sep 1, 2014

Key People

Founding team and executive leadership

Darin Hammers

President And CEO

Executive Team

Greg Simbro

Chief Financial Officer

Executive Team

Axora Medical Investors

Notable investors and investment history

Axora Medical investors
InvestorRounds
New Enterprise Associates (NEA)Series B, Seed, Series C Extension, Series C
Versant VenturesSeries B, Seed, Series C Extension, Series C
Novo HoldingsSeries B, Series C Extension, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 26, 2021

    $75M raised in IPO round.

  • Apr 1, 2010

    $7M round with participation from NEA and Versant Ventures.

Axora Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axora Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axora Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range44
Year Founded2026
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?